China Reform Valuation
| 000503 Stock | 13.01 0.24 1.88% |
At this time, the firm appears to be overvalued. China Reform Health shows a prevailing Real Value of USD10.27 per share. The current price of the firm is USD13.01. Our model approximates the value of China Reform Health from analyzing the firm fundamentals such as Current Valuation of 11.72 B, profit margin of (0.01) %, and Return On Equity of -0.0038 as well as examining its technical indicators and probability of bankruptcy.
Price Book 9.1872 | Enterprise Value 11.7 B | Enterprise Value Ebitda 2.5 K | Price Sales 34.562 | Enterprise Value Revenue 31.7198 |
Overvalued
Today
Please note that China Reform's price fluctuation is somewhat reliable at this time. Calculation of the real value of China Reform Health is based on 3 months time horizon. Increasing China Reform's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since China Reform is currently traded on the exchange, buyers and sellers on that exchange determine the market value of China Stock. However, China Reform's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.01 | Real 10.27 | Hype 13.02 | Naive 13.68 |
The real value of China Stock, also known as its intrinsic value, is the underlying worth of China Reform Health Company, which is reflected in its stock price. It is based on China Reform's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of China Reform's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of China Reform Health helps investors to forecast how China stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of China Reform more accurately as focusing exclusively on China Reform's fundamentals will not take into account other important factors: China Reform Cash |
|
China Reform Total Value Analysis
China Reform Health is presently forecasted to have takeover price of 11.72 B with market capitalization of 12.77 B, debt of 193.94 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the China Reform fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.72 B | 12.77 B | 193.94 M |
China Reform Investor Information
About 29.0% of the company shares are owned by insiders or employees . The company last dividend was issued on the 31st of May 2004. China Reform Health had 12:10 split on the 10th of June 2011. China Reform Health is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.China Reform Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. China Reform has an asset utilization ratio of 16.92 percent. This suggests that the Company is making USD0.17 for each dollar of assets. An increasing asset utilization means that China Reform Health is more efficient with each dollar of assets it utilizes for everyday operations.China Reform Ownership Allocation
China Reform holds a total of 981.31 Million outstanding shares. China Reform Health retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.China Reform Profitability Analysis
The company reported the revenue of 330.13 M. Net Loss for the year was (79.79 M) with profit before overhead, payroll, taxes, and interest of 85.24 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates China Reform's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in China Reform and how it compares across the competition.
About China Reform Valuation
The stock valuation mechanism determines China Reform's current worth on a weekly basis. Our valuation model uses a comparative analysis of China Reform. We calculate exposure to China Reform's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of China Reform's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 94.3 M | 99 M |
Complementary Tools for China Stock analysis
When running China Reform's price analysis, check to measure China Reform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Reform is operating at the current time. Most of China Reform's value examination focuses on studying past and present price action to predict the probability of China Reform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Reform's price. Additionally, you may evaluate how the addition of China Reform to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |